secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2022-11-01T23:59:59+00:00
Accession:  0001558370-22-015710
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q1 FY2023 revenue up 7% organic, GAAP EPS $2.21, declares 4-for-1 stock split
--------------------------------------------------------------------------------

- Total revenue $269.7M, up 5% reported / 7% organic YoY.
- GAAP diluted EPS $2.21 (vs $1.69); adjusted diluted EPS $1.78 (vs $1.83, FX impact $0.12).
- Diagnostics & Genomics segment organic growth of 17%; ExoDx Prostate test revenue +100% YoY.
- Operating cash flow $56.1M, up 16% YoY.
- Board declared $0.32/share quarterly cash dividend (payable Nov 28) and 4-for-1 stock split (distributed Nov 29, trading split-adjusted Nov 30).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837022015710/0001558370-22-015710-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837022015710/tmb-20221027x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-015710

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer